Eli Lilly Obliterates Sales Forecasts By $2 Billion; Shares Surge
Investor's Business Daily • • business
Key Points:
- Investor’s Business Daily provides information solely for educational and informational purposes and does not offer investment advice or recommendations.
- The data presented is sourced from reliable providers but accuracy, timeliness, and suitability are not guaranteed.
- Past investment performance is not indicative of future results, and authors may hold positions in the stocks they discuss.
- The company disclaims warranties on investment strategies and securities advisability, and information is subject to change without notice.
- Real-time market data is provided by Nasdaq, LSEG, and FactSet, but may not cover all markets; trademarks are owned by Investor’s Business Daily, LLC.
